113. 筋ジストロフィー Muscular dystrophy Clinical trials / Disease details


臨床試験数 : 622 薬物数 : 485 - (DrugBank : 99) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 168

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02354352
(ClinicalTrials.gov)
March 20, 201527/1/2015Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular DystrophyTherapeutic Potential for Aldosterone Inhibition in Duchenne Muscular DystrophyDuchenne Muscular DystrophyDrug: Eplerenone;Drug: SpironolactoneOhio State UniversityUniversity of California, Los Angeles;University of Utah;University of Colorado, Denver;University of Kansas Medical Center;Vanderbilt University Medical CenterCompleted7 YearsN/AMale52Phase 3United States
2NCT01521546
(ClinicalTrials.gov)
February 201226/1/2012Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular DystrophyEarly Treatment With Aldosterone Antagonism Attenuates Cardiomyopathy in Duchenne Muscular DystrophyDuchenne Muscular DystrophyDrug: eplerenone;Drug: placeboSubha RamanBallou SkiesCompleted7 YearsN/AMale42N/AUnited States